Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Research & Development: 2009-2021

Historic Research & Development for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Dec 2021 value amounting to $17.1 million.

  • Avadel Pharmaceuticals' Research & Development fell 60.08% to $2.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was $17.1 million, marking a year-over-year decrease of 16.33%. This contributed to the annual value of $17.1 million for FY2021, which is 16.33% down from last year.
  • According to the latest figures from FY2021, Avadel Pharmaceuticals' Research & Development is $17.1 million, which was down 16.33% from $20.4 million recorded in FY2020.
  • In the past 5 years, Avadel Pharmaceuticals' Research & Development ranged from a high of $39.3 million in FY2018 and a low of $17.1 million during FY2021.
  • In the last 3 years, Avadel Pharmaceuticals' Research & Development had a median value of $20.4 million in 2020 and averaged $23.5 million.
  • Its Research & Development has fluctuated over the past 5 years, first increased by 17.69% in 2018, then tumbled by 37.90% in 2020.
  • Over the past 5 years, Avadel Pharmaceuticals' Research & Development (Yearly) stood at $33.4 million in 2017, then increased by 17.69% to $39.3 million in 2018, then fell by 16.30% to $32.9 million in 2019, then tumbled by 37.90% to $20.4 million in 2020, then decreased by 16.33% to $17.1 million in 2021.